Gait analysis using accelerometry in dystrophin-deficient dogs
- PMID: 19800232
- DOI: 10.1016/j.nmd.2009.07.014
Gait analysis using accelerometry in dystrophin-deficient dogs
Abstract
Dogs affected with Golden Retriever Muscular Dystrophy (GRMD) exhibit striking clinical similarities with patients suffering from Duchenne muscular dystrophy (DMD), particularly gait impairments. The purpose of this study was to describe the use and reliability of accelerometry in gait assessment of dogs with muscular dystrophy. Eight healthy and 11 GRMD adult dogs underwent three gait assessment sessions, using accelerometry. Three-axial recordings of accelerations were performed, and gait variables calculated. Total power, force and regularity of accelerations, stride length and speed, normalized by height at withers, stride frequency, and cranio-caudal power were significantly decreased, whereas medio-lateral power was significantly increased in GRMD dogs. Moreover, these variables were repeatable within and between sessions. Accelerometry provides reliable variables which highlight specific gait patterns of GRMD dogs, describing objectively and quantitatively their slow, short-stepped, and swaying gait. As it is easy to set-up, quick to perform and inexpensive, accelerometry represents a useful tool, to assess locomotion during pre-clinical trials.
Similar articles
-
Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs.BMC Musculoskelet Disord. 2011 Apr 13;12:75. doi: 10.1186/1471-2474-12-75. BMC Musculoskelet Disord. 2011. PMID: 21489295 Free PMC article.
-
Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies.J Comp Pathol. 2002 Feb-Apr;126(2-3):100-8. doi: 10.1053/jcpa.2001.0526. J Comp Pathol. 2002. PMID: 11944998
-
Microvessel density in muscles of dogs with golden retriever muscular dystrophy.Neuromuscul Disord. 2005 Feb;15(2):154-63. doi: 10.1016/j.nmd.2004.11.002. Epub 2005 Jan 11. Neuromuscul Disord. 2005. PMID: 15694137
-
The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.Curr Top Dev Biol. 2008;84:431-53. doi: 10.1016/S0070-2153(08)00609-1. Curr Top Dev Biol. 2008. PMID: 19186250 Review.
-
[Current status and perspective of gene therapy on dystrophic animal model].Rinsho Shinkeigaku. 2004 Nov;44(11):911-3. Rinsho Shinkeigaku. 2004. PMID: 15651329 Review. Japanese.
Cited by
-
A dog model for centronuclear myopathy carrying the most common DNM2 mutation.Dis Model Mech. 2022 Apr 1;15(4):dmm049219. doi: 10.1242/dmm.049219. Epub 2022 Apr 14. Dis Model Mech. 2022. PMID: 35244154 Free PMC article.
-
Extraction of canine gait characteristics using a mobile gait analysis system based on inertial measurement units.Vet Anim Sci. 2023 Jun 10;21:100301. doi: 10.1016/j.vas.2023.100301. eCollection 2023 Sep. Vet Anim Sci. 2023. PMID: 37333505 Free PMC article.
-
Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.PLoS One. 2012;7(11):e48478. doi: 10.1371/journal.pone.0048478. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185260 Free PMC article.
-
Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis.BMC Musculoskelet Disord. 2017 Apr 12;18(1):153. doi: 10.1186/s12891-017-1494-4. BMC Musculoskelet Disord. 2017. PMID: 28403854 Free PMC article.
-
Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in Japan.Exp Anim. 2021 Nov 10;70(4):419-430. doi: 10.1538/expanim.21-0072. Epub 2021 Jun 16. Exp Anim. 2021. PMID: 34135266 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials